Noninvasive imaging of apoptosis in cardiovascular disease
- PMID: 18074226
- PMCID: PMC2597223
- DOI: 10.1007/s10741-007-9068-4
Noninvasive imaging of apoptosis in cardiovascular disease
Abstract
Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.
Figures
Similar articles
-
Intracellular and extracellular targets of molecular imaging in the myocardium.Nat Clin Pract Cardiovasc Med. 2008 Aug;5 Suppl 2:S33-41. doi: 10.1038/ncpcardio1161. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18641605 Review.
-
Cardiovascular molecular imaging.Semin Nucl Med. 2005 Jan;35(1):73-81. doi: 10.1053/j.semnuclmed.2004.09.006. Semin Nucl Med. 2005. PMID: 15645396 Review.
-
Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.JACC Cardiovasc Imaging. 2018 Dec;11(12):1823-1833. doi: 10.1016/j.jcmg.2017.11.037. Epub 2018 Feb 14. JACC Cardiovasc Imaging. 2018. PMID: 29454770
-
Annexin A5: an imaging biomarker of cardiovascular risk.Basic Res Cardiol. 2008 Mar;103(2):95-104. doi: 10.1007/s00395-008-0701-8. Basic Res Cardiol. 2008. PMID: 18324365 Review.
-
PET/MR Imaging in Cardiovascular Imaging.PET Clin. 2019 Apr;14(2):233-244. doi: 10.1016/j.cpet.2018.12.005. Epub 2019 Feb 1. PET Clin. 2019. PMID: 30826021 Review.
Cited by
-
Beyond annexin V: fluorescence response of cellular membranes to apoptosis.Cytotechnology. 2013 Mar;65(2):157-72. doi: 10.1007/s10616-012-9481-y. Epub 2012 Jul 14. Cytotechnology. 2013. PMID: 22797774 Free PMC article.
-
Therapeutic Potential of Annexins in Sepsis and COVID-19.Front Pharmacol. 2021 Sep 9;12:735472. doi: 10.3389/fphar.2021.735472. eCollection 2021. Front Pharmacol. 2021. PMID: 34566657 Free PMC article. Review.
-
Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography.Mol Imaging. 2008 May-Jun;7(3):132-8. Mol Imaging. 2008. PMID: 19123983 Free PMC article.
-
Protective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5.Nanomedicine. 2012 Apr;8(3):291-8. doi: 10.1016/j.nano.2011.06.012. Epub 2011 Jun 24. Nanomedicine. 2012. PMID: 21704591 Free PMC article.
-
Multimodality cardiovascular molecular imaging, Part II.Circ Cardiovasc Imaging. 2009 Jan;2(1):56-70. doi: 10.1161/CIRCIMAGING.108.839092. Circ Cardiovasc Imaging. 2009. PMID: 19808565 Free PMC article. Review. No abstract available.
References
-
- Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA. 2005;293(7):855–862. - PubMed
-
- Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2006 - PubMed
-
- Weissleder R. Molecular imaging in cancer. Science. 2006;312(5777):1168–1171. - PubMed
-
- Jaffer FA, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res. 2004;94(4):433–445. - PubMed
-
- Narula J, Kietselaer B, Hofstra L. Role of molecular imaging in defining and denying death. J Nucl Cardiol. 2004;11(3):349–357. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical